Masakazu Haneda

20.3k total citations · 4 hit papers
292 papers, 16.1k citations indexed

About

Masakazu Haneda is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Molecular Biology. According to data from OpenAlex, Masakazu Haneda has authored 292 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Endocrinology, Diabetes and Metabolism, 95 papers in Nephrology and 87 papers in Molecular Biology. Recurrent topics in Masakazu Haneda's work include Chronic Kidney Disease and Diabetes (86 papers), Diabetes Treatment and Management (56 papers) and Pancreatic function and diabetes (39 papers). Masakazu Haneda is often cited by papers focused on Chronic Kidney Disease and Diabetes (86 papers), Diabetes Treatment and Management (56 papers) and Pancreatic function and diabetes (39 papers). Masakazu Haneda collaborates with scholars based in Japan, United States and China. Masakazu Haneda's co-authors include Daisuke Koya, Ryuichi Kikkawa, Toshiro Sugimoto, Atsunori Kashiwagi, Shin‐ichi Araki, Keiji Isshiki, Takashi Uzu, Atsunori Kashiwagi, Shinji Kume and Eiichi Araki and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Masakazu Haneda

281 papers receiving 15.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

2010 1.5k citations Takashi Kadowaki, Atsunori Kashiwagi et al. Journal of Diabetes Investigation profile →
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus

2010 520 citations Takashi Kadowaki, Atsunori Kashiwagi et al. Diabetology International profile →
Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney

2010 501 citations Shinji Kume, Takashi Uzu et al. profile →
Japanese Clinical Practice Guideline for Diabetes 2016

2018 268 citations Masakazu Haneda, Yukihiro Fujita et al. Diabetology International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masakazu Haneda Japan	67	5.4k	4.8k	3.5k	2.7k	2.5k	292	16.1k
Daisuke Koya Japan	75	4.1k 0.8×	6.6k 1.4×	4.1k 1.2×	2.4k 0.9×	3.4k 1.3×	292	18.9k
Kumar Sharma United States	76	3.9k 0.7×	7.6k 1.6×	6.9k 1.9×	2.8k 1.0×	2.1k 0.8×	216	19.1k
Andrzej S. Królewski United States	63	5.8k 1.1×	3.1k 0.7×	5.3k 1.5×	3.2k 1.2×	1.6k 0.6×	190	15.7k
James H. Warram United States	68	6.4k 1.2×	3.5k 0.7×	5.2k 1.5×	3.5k 1.3×	2.0k 0.8×	190	17.3k
Michel Marre France	66	8.7k 1.6×	3.9k 0.8×	2.3k 0.6×	3.3k 1.2×	1.9k 0.7×	423	17.2k
Giancarlo Viberti United Kingdom	62	6.6k 1.2×	3.7k 0.8×	4.0k 1.1×	2.1k 0.8×	844 0.3×	190	13.7k
Rama Natarajan United States	79	2.8k 0.5×	10.0k 2.1×	2.0k 0.6×	2.3k 0.8×	1.6k 0.6×	246	18.5k
Carol Forsblom Finland	60	5.2k 1.0×	2.4k 0.5×	2.3k 0.7×	2.5k 0.9×	1.7k 0.7×	276	12.2k
Marta Ruiz‐Ortega Spain	70	2.2k 0.4×	6.9k 1.4×	4.7k 1.3×	2.0k 0.7×	1.4k 0.6×	265	18.2k
Lise Tarnow Denmark	63	5.2k 1.0×	2.1k 0.4×	2.9k 0.8×	1.8k 0.7×	903 0.4×	279	12.1k

Countries citing papers authored by Masakazu Haneda

Since Specialization

Citations

This map shows the geographic impact of Masakazu Haneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Haneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Haneda more than expected).

Fields of papers citing papers by Masakazu Haneda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Haneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Haneda. The network helps show where Masakazu Haneda may publish in the future.

Co-authorship network of co-authors of Masakazu Haneda

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Haneda. A scholar is included among the top collaborators of Masakazu Haneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Haneda. Masakazu Haneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shikata, Kenichi, Masakazu Haneda, Toshiharu Ninomiya, et al.. (2020). Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan). Journal of Diabetes Investigation. 12(2). 207–216. 17 indexed citations

Takahara, Mitsuyoshi, Shota Okuno, Izumi Nakamura, et al.. (2019). Prospective study on clinical characteristics of Japanese diabetic patients with chronic limb-threatening ischemia presenting Fontaine stage IV. Diabetology International. 11(1). 33–40. 9 indexed citations

Takiyama, Yumi, Toshihiro Sera, Masanori Nakamura, et al.. (2018). Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8. EBioMedicine. 36. 329–346. 29 indexed citations

Oshima, Megumi, Tadashi Toyama, Masakazu Haneda, et al.. (2018). Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLoS ONE. 13(8). e0201535–e0201535. 27 indexed citations

Kadowaki, Takashi, Masakazu Haneda, Hiroshi Ito, et al.. (2018). Safety and efficacy of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in monotherapy and in combination therapy with antihyperglycemic agents in patients with type 2 diabetes mellitus - An interim analysis of post-marketing surveillance, RUBY-. 46(4). 481–498.

Takahara, Mitsuyoshi, Osamu Iida, Yukihiro Fujita, & Masakazu Haneda. (2018). Clinical characteristics of Japanese diabetic patients with critical limb ischemia presenting Fontaine stage IV. Diabetology International. 10(3). 231–235. 11 indexed citations

Haneda, Masakazu, Kazunori Utsunomiya, & Daisuke Koya. (2014). REPORT OF THE COMMITTEE : A new classification of Diabetic Nephropathy 2014 : a report from Joint Committee on Diabetic Nephropathy. Diabetology International. 5(4). 207–211. 1 indexed citations

Yokoyama, Hiroki, Shin‐ichi Araki, Masakazu Haneda, et al.. (2012). Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia. 55(7). 1911–1918. 39 indexed citations

Kume, Shinji, Keiji Isshiki, Naoko Takeda, et al.. (2010). Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. Biochemical and Biophysical Research Communications. 402(2). 265–271. 69 indexed citations

10.

Koya, Daisuke, Masakazu Haneda, S. Inomata, et al.. (2009). Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial. Diabetologia. 52(10). 2037–2045. 64 indexed citations

11.

Haneda, Masakazu. (2009). 2. Diabetic Nephropathies. Nihon Naika Gakkai Zasshi. 98(4). 773–778. 1 indexed citations

12.

Hirano, Fuminori, et al.. (2009). Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity. Suizo. 24(4). 556–558. 2 indexed citations

13.

Sugimoto, Toshiro, Shinji Kume, Shin‐ichi Araki, et al.. (2008). Asialoerythropoietin Prevents Contrast-Induced Nephropathy. Journal of the American Society of Nephrology. 19(2). 321–328. 72 indexed citations

14.

Haneda, Masakazu. (2007). 3. Diabetes Mellitus. Nihon Naika Gakkai Zasshi. 96(5). 899–903.

15.

Uzu, Takashi, Genjiro Kimura, Atsushi Yamauchi, et al.. (2006). Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. Journal of Hypertension. 24(8). 1627–1632. 104 indexed citations

16.

Hayashi, Kazuyuki, Masakazu Haneda, Daisuke Koya, et al.. (2001). Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Research and Clinical Practice. 52(2). 85–96. 60 indexed citations

17.

Chiba, Mikio, Hiroki Konishi, Tokuzo Minouchi, et al.. (2001). Assessment of Comprehension Levels of Inpatients with Diabetes Mellitus. Educational Significance for Enhancement of Therapeutic Outcome.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 27(4). 317–322. 2 indexed citations

18.

Nakagawa, Hiroko, Satoru Suzuki, Masakazu Haneda, Fumitake Gejyo, & Ryuichi Kikkawa. (2000). Significance of Glomerular Deposition of C3c and C3d in IgA Nephropathy. American Journal of Nephrology. 20(2). 122–128. 26 indexed citations

19.

Suzuki, Eiji, Atsunori Kashiwagi, Yusuke Nishio, et al.. (2000). Usefulness of waveform analysis of popliteal artery in Type II diabetic patients using gated magnetic resonance 2D-cine-PC imaging and 31 P spectroscopy. Diabetologia. 43(8). 1031–1038. 11 indexed citations

20.

Araki, Shin‐ichi, Ryuichi Kikkawa, Masakazu Haneda, et al.. (1995). Microalbuminuria cannot predict cardiovascular death in Japanese subjects with non-insulin-dependent diabetes mellitus. Journal of Diabetes and its Complications. 9(4). 323–325. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact